| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.362 | 55.538 | 52.944 | 32.019 | 53.834 | 76.646 | 142.737 | 151.613 | 4.865 | 0 |
| Total Income - EUR | 48.362 | 55.538 | 52.945 | 32.019 | 55.902 | 77.056 | 142.737 | 152.717 | 4.866 | 0 |
| Total Expenses - EUR | 23.253 | 26.376 | 23.209 | 23.786 | 23.778 | 41.646 | 104.366 | 125.403 | 11.066 | 5.103 |
| Gross Profit/Loss - EUR | 25.109 | 29.162 | 29.736 | 8.233 | 32.124 | 35.411 | 38.371 | 27.314 | -6.199 | -5.103 |
| Net Profit/Loss - EUR | 23.658 | 27.496 | 28.148 | 7.273 | 30.509 | 34.195 | 36.924 | 25.787 | -6.199 | -5.103 |
| Employees | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Recons Inject Srl
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.181 | 2.186 | 1.827 | 1.478 | 2.745 | 19.176 | 15.701 | 9.310 | 3.944 | 1.190 |
| Current Assets | 50.669 | 36.119 | 37.022 | 14.476 | 37.390 | 37.849 | 68.575 | 127.763 | 7.852 | 3.683 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.627 | 4.702 | 180 | 746 | 557 | 6.861 | 29.804 | 14.298 | 455 | 0 |
| Cash | 43.043 | 31.417 | 36.843 | 13.730 | 36.833 | 30.988 | 38.771 | 113.465 | 7.397 | 3.683 |
| Shareholders Funds | 31.253 | 34.962 | 35.391 | 14.376 | 37.477 | 52.648 | 43.759 | 50.618 | 10.111 | 4.873 |
| Social Capital | 111 | 109 | 107 | 105 | 103 | 101 | 101 | 101 | 101 | 99 |
| Debts | 27.598 | 3.343 | 3.458 | 1.578 | 2.658 | 4.378 | 40.516 | 86.455 | 1.685 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 5.0415 | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 |
| Main CAEN | "4120 - 4120" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Recons Inject Srl